Stockholders’ Equity and Equity Incentive Plan - Common Stock Reserved for Future Issuance (Details) - shares |
Jan. 01, 2025 |
Mar. 31, 2025 |
|---|---|---|
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
| Stock options outstanding (in shares) | 5,241,756 | |
| Number of shares available for future issuance (in shares) | 17,692,236 | |
| 2021 Equity Incentive Plan | ||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
| Common stock, shares available for grant (in shares) | 3,943,021 | |
| Number of additional shares authorized (in shares) | 2,100,684 | |
| 2021 Employee Stock Purchase Plan | Employee Stock | ||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
| Common stock, shares available for grant (in shares) | 2,528,247 | |
| Number of additional shares authorized (in shares) | 420,136 | |
| Restricted Stock | ||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
| Restricted stock outstanding (in shares) | 5,979,212 |
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of additional shares authorized for issuance under share-based payment arrangement. No definition available.
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|